Christopher W. Schmidt

2 papers in the library · 39 citations · publishing 2022-2024

Papers

Measuring psychotherapeutic processes in the context of psychedelic experiences: Validation of the General Change Mechanisms Questionnaire (GCMQ)

Journal of Psychopharmacology May 1, 2024 Max Wolff, Ricarda Evens, Lea J. Mertens et al. 34 citations

A new questionnaire, the General Change Mechanisms Questionnaire (GCMQ), reliably measures five psychotherapy processes—resource activation, therapeutic relationship, problem actuation, clarification, and mastery—during psychedelic experiences. Validated in 1153 English-speaking and 714 German-speaking users, the GCMQ showed good internal consistency and convergent validity. Experiences varied with setting and use motives (therapeutic, hedonic, escapist). Resource activation, clarification, and mastery moderated the link between stressful life events and well-being, suggesting potential therapeutic benefits. Five distinct user profiles emerged, which may inform clinical use and harm reduction.

DOI: 10.1177/02698811241249698 Clinical psychology Context archaeology Psychotherapist

Einstellungen von Expertinnen und Experten für psychische Gesundheit gegenüber Psilocybin

Fortschritte der Neurologie · Psychiatrie June 20, 2022 Christopher W. Schmidt, Max Wolff, Gerhard Gründer et al. 5 citations

A survey of 530 psychiatrists and psychotherapists found divided opinions about psilocybin and psilocybin-assisted therapies. Many respondents considered psilocybin promising for treating mental disorders, with a majority viewing it as promising for depression. Greater knowledge about psilocybin was linked to more optimistic views about its therapeutic use. Providing additional scientific information about current research partly led to more favorable attitudes. As scientific and public discourse on psilocybin grows, shifts in psychotherapists' and psychiatrists' attitudes are expected.

DOI: 10.1055/a-1846-1161 Psilocybin Psychology Political science